Periodontitis, Porphyromonas, and the pathogenesis of rheumatoid arthritis

Mucosal Immunology

Volumn 5, Issue 2, 2012, Pages 112-120

  Farquharson, D ^a   Butcher, J P ^b   Culshaw, S ^a  

^a GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ENOLASE; AUTOANTIBODY; AUTOANTIGEN; BACTERIAL PROTEIN; COLLAGEN TYPE 2; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; FIBRINOGEN; HLA DR4 ANTIGEN; PROTEIN ARGININE DEIMINASE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VIMENTIN;

CIGARETTE SMOKING; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; EPIDEMIOLOGICAL DATA; ERYTHROCYTE SEDIMENTATION RATE; HEREDITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOUTH HYGIENE; NONHUMAN; PATHOGENESIS; PERIODONTICS; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN PROCESSING; RECEPTOR UPREGULATION; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; TREATMENT OUTCOME;

EID: 84857226677     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2011.66     Document Type: Review

References (145)

1. Loe, H ., Anerud, A ., Boysen, H. & Morrison, E. Natural history of periodontal disease in man. Rapid, moderate and no loss of attachment in Sri Lankan laborers 14 to 46 years of age. J. Clin. Periodontol. 13, 431-445 (1986).
2. Hugoson, A ., Sjödin, B. & Norderyd, O. Trends over 30 years, 1973-2003, in the prevalence and severity of periodontal disease. J. Clin. Periodontol. 35, 405-414 (2008).
3. Morris, A. J ., Steele, J. & White, D. A. Adult dental health survey: the oral cleanliness and periodontal health of UK adults in 1998. Br. Dent. J. 191, 186-192 (2001). (Pubitemid 33755285)
4. Armitage, G. C. Periodontal diagnoses and classification of periodontal diseases. Periodontol. 2000 34, 9-21 (2004). (Pubitemid 41794526)
5. Kebschull, M ., Demmer, R. T. & Papapanou, P. N. Gum bug, leave my heart alone! Epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. J. Dent. Res. 89, 879-902 (2010).
6. Trombone, A. P. et al. Periodontitis and arthritis interaction in mice involves a shared hyper-inflammatory genotype and functional immunological interferences. Genes Immun. 11, 479-489 (2010).
7. Kinane, D. F. & Mark Bartold, P. Clinical relevance of the host responses of periodontitis. Periodontol. 2000 43, 278-293 (2007).
8. Berglundh, T. & Donati, M. Aspects of adaptive host response in periodontitis. J. Clin. Periodontol. 32 (Suppl 6), 87-107 (2005). (Pubitemid 41391059)
9. Socransky, S. S ., Cugini, M. A ., Smith, C. & Kent, R. L. Jr Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25, 134-144 (1998). (Pubitemid 128705944)
10. Kumar, P ., Leys, E. J ., Bryk, J. M ., Martinez, F. J ., Moeschberger, M. L. & Griffen, A. L. Changes in periodontal health status are associated with bacterial community shifts as assessed by quantitative 16S cloning and sequencing. J. Clin. Microbiol. 44, 3665-3673 (2006). (Pubitemid 46768783)
11. Socransky, S. S. & Haffajee, A. D. Effect of therapy on periodontal infections. J. Periodontol. 64 (8 Suppl), 754-759 (1993). (Pubitemid 23278148)
12. Hajishengallis, G. et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 10, 497-506 (2011).
13. Holt, S. C ., Kesavalu, L ., Walker, S. & Genco, C. A. Virulence factors of Porphyromonas gingivalis. Periodontol. 2000 20, 168-238 (1999).
14. Kesavalu, L ., Holt, S. C. & Ebersole, J. L. Trypsin-like protease activity of Porphyromonas gingivalis as a potential virulence factor in a murine lesion model. Microb. Pathog. 20, 1-10 (1996).
15. Birkedal-Hansen, H ., Taylor, R. E ., Zambon, J. J ., Barwa, P. K. & Neiders, M. E. Characterization of collagenolytic activity from strains of Bacteroides gingivalis. J. Periodontal. Res. 23, 258-264 (1988).
16. Lamont, R. J. & Jenkinson, H. F. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol. Mol. Biol. Rev. 62, 1244-1263 (1998). (Pubitemid 28558298)
17. Curtis, M. A ., Aduse-Opoku, J. & Rangarajan, M. Cysteine proteases of Porphyromonas gingivalis. Crit. Rev. Oral Biol. Med. 12, 192-216 (2001). (Pubitemid 32666404)
18. Guo, Y ., Nguyen, K-A. & Potempa, J. Dichotomy of gingipains action as virulence factors: from cleaving substrates with the precision of a surgeon's knife to a meat chopper-like brutal degradation of proteins. Periodontol. 2000 54, 15-44 (2010).
19. McGraw, W. T ., Potempa, J ., Farley, D. & Travis, J. Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infection Immunity 67, 3248-3256 (1999). (Pubitemid 29291488)
20. Wegner, N. et al. Peptidylarginine deiminase from porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum. 62, 2662-2672 (2010).
21. Firestein, G. S. Evolving concepts of rheumatoid arthritis. Nature 423, 356-361 (2003). (Pubitemid 40852711)
22. Vincent, C. et al. High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called 'antikeratin antibodies. Ann. Rheum. Dis. 48, 712-722 (1989). (Pubitemid 19225042)
23. Cordonnier, C. et al. Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor. Br. J. Rheumatol. 35, 620-624 (1996).
24. van Venrooij, W. J. & Pruijn, G. J. Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res. 2, 249-251 (2000). (Pubitemid 32223741)
25. Schellekens, G. A. et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 43, 155-163 (2000). (Pubitemid 30368225)
26. Zendman, A. J. W ., Vossenaar, E. R. & Van Venrooij, W. J. Autoantibodies to citrullinated (poly)peptides: a key diagnostic and prognostic marker for rheumatoid arthritis. Autoimmunity 37, 295-299 (2004). (Pubitemid 39172915)
27. van Gaalen, F. A. et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum. 50, 2113-2121 (2004). (Pubitemid 38924388)
28. Meyer, O. et al. Anticitrullinated protein/pepticle antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann. Rheum. Dis. 62, 120-126 (2003). (Pubitemid 36135386)
29. Nielen, M. M. J. et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis-a study of serial measurements in blood donors. Arthritis Rheum. 50, 380-386 (2004). (Pubitemid 38198821)
30. Klareskog, L ., Ronnelid, J ., Lundberg, K ., Padyukov, L. & Alfredsson, L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu. Rev. Immunol. 26, 651-675 (2008). (Pubitemid 351600388)
31. van Gaalen, F ., Ioan-Facsinay, A ., Huizinga, T. W. J. & Toes, R. E. M. The devil in the details: the emerging role of anticitrulline autoimmunity in rheumatoid arthritis. J. Immunol. 175, 5575-5580 (2005). (Pubitemid 41508033)
32. Suwannalai, P ., Trouw, L. A ., Toes, R. E. & Huizinga, T. W. Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis. Mod. Rheumatol. Published online 6 July 2011.
33. Erill, S ., Calvo, R. & Carlos, R. Plasma protein carbamylation and decreased acidic drug protein binding in uremia. Clin. Pharmacol. Ther. 27, 612-618 (1980). (Pubitemid 10105592)
34. Fluckiger, R ., Harmon, W ., Meier, W ., Loo, S. & Gabbay, K. H. Hemoglobin carbamylation in uremia. N Engl. J. Med. 304, 823-827 (1981). (Pubitemid 11147484)
35. Van Lente, F ., McHugh, A. & Pippenger, C. E. Carbamylation of apo-aspartate aminotransferase: a possible mechanism for enzyme inactivation in uremic patients. Clin. Chem. 32, 2107-2108 (1986).
36. Mydel, P. et al. Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis. J. Immunol. 15, 6882-6890 (2010).
37. Shi, J. et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc. Natl Acad. Sci. USA 108, 17372-17377 (2011).
38. Liubomorova, I. State of periodontium in patients affected with rheumatism. Stomatologiia 43, 33-37 (1964).
39. Snyderman, R. & McCarty, G. A. Analogous mechanisms of tissue destruction in rheumatoid arthritis and periodontal disease. In (R.J. Genco SEM, ed) (American Society of Microbiology, Washington, DC, 1982 ).
40. Mercado, F ., Marshall, R. I ., Klestov, A. C. & Bartold, P. M. Is there a relationship between rheumatoid arthritis and periodontal disease? J. Clin. Periodontol. 27, 267-272 (2000).
41. Mercado, F. B ., Marshall, R. I ., Klestov, A. C. & Bartold, P. M. Relationship between rheumatoid arthritis and periodontitis. J. Periodontol. 72, 779-787 (2001). (Pubitemid 33606561)
42. Arkema, E. V ., Karlson, E. W. & Costenbader, K. H. A prospective study of periodontal disease and risk of rheumatoid arthritis. J. Rheumatol. 37, 1800-1804 (2010).
43. Abdelsalam, S. K ., Hashim, N. T ., Elsalamabi, E. M. & Gismalla, B. G. Periodontal status of rheumatoid arthritis patients in Khartoum state. BMC Res. Notes 28, 460 (2011).
44. Gleissner, C ., Willershausen, B ., Kaesser, U. & Bolten, W. W. The role of risk factors for periodontal disease in patients with rheumatoid arthritis. Eur. J. Med. Res. 18, 387-392 (1998).
45. Kasser, U ., Gleissner, C ., Dehne, F ., Michel, A ., Willershausen- Zonnchen, B. & Bolten, W. W. Risk for periodontal disease in patients with longstanding rheumatoid arthritis. Arthritis. Rheum. 40, 2248-2251 (1997). (Pubitemid 28016423)
46. Cooles, F. A. & Isaacs, J. D. Pathophysiology of rheumatoid arthritis. Curr. Opin. Rheumatol. 23, 233-240 (2011).
47. de Pablo, P ., Dietrich, T. & McAlindon, T. E. Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J. Rheumatol. 35, 70-76 (2008).
48. Dissick, A. et al. Association of periodontitis with rheumatoid arthritis: a pilot study. J. Periodontol. 81, 223-230 (2010).
49. Rosenstein, E ., Greenwald, R ., Kushner, L. & Weissmann, G. Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis. Inflammation 28, 311-318 (2004). (Pubitemid 41504274)
50. Haffajee, A. D. & Socransky, S. S. Microbial etiological agents of destructive periodontal diseases. Periodontol. 2000 5, 78-111 (1994).
51. Hitchon, C. A. et al. Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives. J. Rheumatol. 37, 1105-1112 (2010).
52. Preshaw, P. M. Definitions of periodontal disease in research. J. Clin. Periodontol. 36, 1-2 (2009).
53. Nesse, W ., Abbas, F ., van der Ploeg, I ., Spijkervet, F. K. L ., Dijkstra, P. U. & Vissink, A. Periodontal inflamed surface area: quantifying inflammatory burden. J. Clin. Periodontol. 35, 668-673 (2008).
54. Ribeiro, J ., Leao, A. & Novaes, A. B. Periodontal infection as a possible severity factor for rheumatoid arthritis. J. Clin. Periodontol. 32, 412-416 (2005). (Pubitemid 40569605)
55. Al-Katma, M. K ., Bissada, N. F ., Bordeaux, J. M ., Sue, J. & Askari, A. D. Control of periodontal infection reduces the severity of active rheumatoid arthritis. J. Clin. Rheumatol. 13, 134-137 (2007). (Pubitemid 46884200)
56. Ortiz, P. et al. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J. Periodontol. 80, 535-540 (2009).
57. Pers, J. O ., Saraux, A ., Pierre, R. & Youinou, P. Anti-TNF-alpha immunotherapy is associated with increased gingival inflammation without clinical attachment loss in subjects with rheumatoid arthritis. J. Periodontol. 79, 1645-1651 (2008).
58. Mayer, Y ., Balbir-Gurman, A. & Machtei, E. E. Anti-tumor necrosis factoralpha therapy and periodontal parameters in patients with rheumatoid arthritis. J. Periodontol. 80, 1414-1420 (2009).
59. Bartold, P. M ., Marino, V ., Cantley, M. & Haynes, D. R. Effect of Porphyromonas gingivalis-induced inflammation on the development of rheumatoid arthritis. J. Clin. Periodontol. 37, 405-411 (2010).
60. Cantley, M. D ., Haynes, D. R ., Marino, V. & Bartold, P. M. Pre-existing periodontitis exacerbates experimental arthritis in a mouse model. J. Clin. Periodontol. 38, 532-541 (2011).
61. Park, J. C. et al. Mechanism of alveolar bone loss in a collagen-induced arthritis model in mice. J. Clin. Periodontol. 38, 122-130 (2011).
62. Queiroz-Junior, C. M. et al. Experimental arthritis triggers periodontal disease in mice: involvement of TNF and the oral microbiota. J. Immunol. 187, 3821-3830 (2011).
63. Ramamurthy, H. S ., Greenwald, R. A ., Celiker, M. Y. & Shi, E. Y. Experimental arthritis in rats induces biomarkers of periodontitis which are ameliorated by gene therapy with tissue inhibitor of matrix metalloproteinases. J. Periodontol. 76, 229-233 (2005). (Pubitemid 40542250)
64. Mangat, P ., Wegner, N ., Venables, P. J. & Potempa, J. Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?. Arthritis Res. Ther. 12, 209 (2010).
65. Rodriguez, S. B ., Stitt, B. L. & Ash, D. E. Cysteine 351 is an essential nucleophile in catalysis by Porphyromonas gingivalis peptidylarginine deiminase. Arch. Biochem. Biophys. 504, 190-196 (2010).
66. Saulot, V. et al. Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis. Arthritis Rheum. 46, 1196-1201 (2002). (Pubitemid 34525825)
67. Kinloch, A. et al. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res. Ther. 7, R1421-R1429 (2005).
68. Mahdi, H. et al. Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat. Genet. 41, 1319-1324 (2009).
69. Kinloch, A. et al. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum. 58, 2287-2295 (2008).
70. Lundberg, K ., Wegner, N ., Yucel-Lindberg, T. & Venables, P. J. Periodontitis in RA the citrullinated enolase connection. Nat. Rev. Rheumatol. 6, 727-730 (2010).
71. Lundberg, K. et al. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum. 58, 3009-3019 (2008).
72. Kinloch, A. J. et al. Immunisation with Porphyromonas gingivalis enolase induces autoimmunity to mammalian alpha-enolase and arthritis in DR4-IE transgenic mice. Arthritis Rheum. 63, 3818-3823 (2011).
73. Hill, J. A. et al. Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J. Exp. Med. 205, 967-979 (2008). (Pubitemid 351549891)
74. Brinkmann, V. et al. Neutrophil extracellular traps kill bacteria. Science 5663, 1532-1535 (2004). (Pubitemid 38314426)
75. Brinkmann, V. & Zychlinsky, A. Beneficial suicide: why neutrophils die to make NETs. Nat. Rev. Microbiol. 5, 577-582 (2007). (Pubitemid 47074113)
76. Neeli, I ., Khan, S. N. & Radic, M. Histone deimination as a response to inflammatory stimuli in neutrophils. J. Immunol. 180, 1895-1902 (2008).
77. Wang, Y. M. et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J. Cell Biol. 184, 205-213 (2009).
78. Li, P ., Li, M ., Lindberg, M. R ., Kennett, M. J ., Xiong, N. & Wang, Y. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med. 207, 1853-1862 (2010).
79. Vitkov, L ., Klappacher, M ., Hannig, M. & Krautgartner, W. D. Extracellular neutrophil traps in periodontitis. J. Periodontal. Res. 44, 664-672 (2009).
80. Sirpal, S. Myeloperoxidase-mediated lipoprotein carbamylation as a mechanistic pathway for atherosclerotic vascular disease. Clin. Sci. 116, 681-695 (2009).
81. Smith, Q. T ., Hinrichs, J. E. & Melnyk, R. S. Gingival crevicular fluid myeloperoxidase at periodontitis sites. J. Periodontal. Res. 21, 45-55 (1986). (Pubitemid 16142750)
82. Cao, C. F. & Smith, Q. T. Crevicular fluid myeloperoxidase at healthy, gingivitis and periodontitis sites. J. Clin. Periodontol. 16, 17-20 (1989).
83. Buchmann, R ., Hasilik, A ., Van Dyke, T. E. & Lange, D. E. Resolution of crevicular fluid leukocyte activity in patients treated for aggressive periodontal disease. J. Periodontol. 73, 995-1002 (2002).
84. Wang, Z. et al. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat. Med. 13, 1176-1184 (2007). (Pubitemid 47530630)
85. Jaisson, S ., Delevallee-Forte, C ., Toure, F ., Rieu, P ., Garnotel, R. & Gillery, P. Carbamylated albumin is a potent inhibitor of polymorphonuclear neutrophil respiratory burst. FEBS Lett. 581, 1509-1513 (2007). (Pubitemid 46463961)
86. Garnotel, R ., Sabbah, N ., Jaisson, S. & Gillery, P. Enhanced activation of and increased production of matrix metalloproteinase-9 by human blood monocytes upon adhering to carbamylated collagen. FEBS Lett. 563, 13-16 (2004). (Pubitemid 38471566)
87. Yilmaz, O ., Verbeke, P ., Lamont, R. J. & Ojcius, D. M. Intercellular spreading of Porphyromonas gingivalis infection in primary gingival epithelial cells. Infect. Immun. 74, 703-710 (2006). (Pubitemid 43023126)
88. Carrion, J. A. G. Y. & Cutler, C. Pathogen trafficking dendritic cells in periodontitis: links to coronary artery disease IADR; San Diego, CA. J. Dent. Res. (www.dentalresearch.org). abstract number 2809 (2011).
89. Crasta, K ., Mitchell, D ., Curtis, B ., Stewart, D. & Heitz-Mayfield, L. J. A. Bacteraemia due to dental flossing. J. Clin. Periodontol. 36, 323-332 (2009).
90. Pitiphat, W ., Joshipura, K. J ., Gillman, M. W ., Williams, P. L ., Douglass, C. W. & Rich-Edwards, J. W. Maternal periodontitis and adverse pregnancy outcomes. Community Dent. Oral Epidemiol. 36, 3-11 (2008).
91. Haraszthy, V. I ., Zambon, J. J ., Trevisan, M ., Zeid, M. & Genco, R. J. Identification of periodontal pathogens in atheromatous plaques. J. Periodontol. 71, 1554-1560 (2000).
92. Fiehn, N. E ., Larsen, T ., Christiansen, N ., Holmstrup, P. & Schroeder, T. V. Identification of periodontal pathogens in atherosclerotic vessels. J. Periodontol. 76, 731-736 (2005). (Pubitemid 40852385)
93. Padilla, C. et al. Periodontal pathogens in atheromatous plaques isolated from patients with chronic periodontitis. J. Periodontal. Res. 41, 350-353 (2006). (Pubitemid 44392307)
94. Romano, F ., Barbui, A. & Aimetti, M. Periodontal pathogens in periodontal pockets and in carotid atheromatous plaques. Minerva Stomatol. 56, 169-179 (2007).
95. Martinez-Martinez, R. E ., Abud-Mendoza, C ., Patino-Marin, N ., Rizo-Rodriguez, J. C ., Little, J. W. & Loyola-Rodriguez, J. P. Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patients. J. Clin. Periodontol. 36, 1004-1010 (2009).
96. Moen, K. et al. Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clin. Exp. Rheumatol. 24, 656-663 (2006). (Pubitemid 46138797)
97. Kozarov, E. V ., Dorn, B. R ., Shelburne, C. E ., Dunn, W. A. Jr & Progulske- Fox, A. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler. Thromb. Vasc. Biol. 25, 17-18 (2005).
98. van der Heijden, I. M. et al. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum. 43, 593-598 (2000). (Pubitemid 30394951)
99. Drexler, S. K. & Foxwell, B. M. The role of Toll-like receptors in chronic inflammation. Int. J. Biochem. Cell Biol. 42, 506-518 (2010).
100. Bainbridge, B. W ., Coats, S. R. & Darveau, R. P. Porphyromonas gingivalis lipopolysaccharide displays functionally diverse interactions with the innate host defense system. Ann. Periodontol. 7, 29-37 (2002).
101. Sahingur, S. E ., Xia, X. J ., Alamgir, S ., Honma, K ., Sharma, A. & Schenkein, H. A. DNA from Porphyromonas gingivalis and Tannerella forsythia induce cytokine production in human monocytic cell lines. Mol. Oral Microbiol. 25, 23-35 (2010).
102. Sokolove, J ., Zhao, X ., Chandra, P. E. & Robinson, W. H. Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcgamma receptor. Arthritis Rheum. 63, 53-62 (2011).
103. D'Aiuto, F. et al. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J. Dent. Res. 83, 156-160 (2004). (Pubitemid 41713801)
104. Schenkein, H. A ., Koertge, T. E ., Brooks, C. N ., Sabatini, R ., Purkall, D. E. & Tew, J. G. IL-17 in Sera from patients with aggressive periodontitis. J. Dent. Res. 89, 943-947 (2010).
105. Cardoso, C. R. et al. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol. Immunol. 24, 1-6 (2009).
106. Zeituni, A. E ., Carrion, J. & Cutler, C. W. Porphyromonas gingivalisdendritic cell interactions: consequences for coronary artery disease. J. Oral. Microbiol. Published online 21 December 2010.
107. Berglundh, T ., Liljenberg, B ., Tarkowski, A. & Lindhe, J. The presence of local and circulating autoreactive B cells in patients with advanced periodontitis. J. Clin. Periodontol. 29, 281-286 (2002). (Pubitemid 41697838)
108. Jagannathan, M. et al. TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients. J. Immunol. 83, 7461-7470 (2009).
109. McInnes, I. B. & O'Dell, J. R. State-of-the-art: rheumatoid arthritis. Ann. Rheum. Dis. 69, 1898-1906 (2010).
110. Bax, M ., van Heemst, J ., Huizinga, T. W. & Toes, R. E. Genetics of rheumatoid arthritis: what have we learned? Immunogenetics 63, 459-466 (2011).
111. Katz, J ., Goultschin, J ., Benoliel, R. & Brautbar, C. Human leukocyte antigen (HLA) DR4. Positive association with rapidly progressing periodontitis. J. Periodontol. 58, 607-610 (1987).
112. Stein, J ., Reichert, S ., Gautsch, A. & Machulla, H. K. G. Are there HLA combinations typical supporting for or making resistant against aggressive and/or chronic periodontitis? J. Periodontal. Res. 38, 508-517 (2003). (Pubitemid 37463787)
113. Dyer, J. K. et al. HLA-D types and serum IgG responses to Capnocytophaga in diabetes and periodontitis. J. Dent. Res. 76, 1825-1832 (1997). (Pubitemid 127732207)
114. Alley, C. S. et al. HLA-D and T lymphocyte reactivity to specific periodontal pathogens in type 1 diabetic periodontitis. J. Periodontol. 64, 974-979 (1993).
115. Machulla, H. K ., Stein, J ., Gautsch, A ., Langner, J ., Schaller, H. G. & Reichert, S. HLA-A, B, Cw, DRB1, DRB3/4/5, DQB1 in German patients suffering from rapidly progressive periodontitis (RPP) and adult periodontitis (AP). J. Clin. Periodontol. 29, 573-579 (2002). (Pubitemid 41705028)
116. Bonfil, J. J. et al. A "case control" study on the role of HLA DR4 in severe periodontitis and rapidly progressive periodontitis-identification of types and subtypes using molecular biology (PCR.SSO). J. Clin. Periodontol. 26, 77-84 (1999).
117. Reinholdt, J ., Bay, I. & Svejgaard, A. Association between HLA-antigens and periodontal disease. J. Dent. Res. 56, 1261-1263 (1977). (Pubitemid 8286654)
118. Moses, J. H ., Tsichti, H ., Donaldson, P ., Smith, P. B ., Johnson, N. W. & Bodmer, J. G. HLA and susceptibility to juvenile periodontitis in Afro-Caribbeans. Tissue Antigens 43, 316-319 (1994). (Pubitemid 24181280)
119. Takashiba, S ., Ohyama, H ., Oyaizu, K ., Kogoe-Kato, N. & Murayama, Y. HLA genetics for diagnosis of susceptibility to early-onset periodontitis. J. Periodontal. Res. 34, 374-378 (1999).
120. Stein, J. M ., Machulla, H. K ., Smeets, R ., Lampert, F. & Reichert, S. Human leukocyte antigen polymorphism in chronic and aggressive periodontitis among Caucasians: a meta-analysis. J. Clin. Periodontol. 35, 183-192 (2008).
121. Calsina, G ., Ramon, J. M. & Echeverria, J. J. Effects of smoking on periodontal tissues. J. Clin. Periodontol. 29, 771-776 (2002). (Pubitemid 41697819)
122. Ah, M. K ., Johnson, G. K ., Kaldahl, W. B ., Patil, K. D. & Kalkwarf, K. L. The effect of smoking on the response to periodontal therapy. J. Clin. Periodontol. 21, 91-97 (1994).
123. Haffajee, A. D. & Socransky, S. S. Relationship of cigarette smoking to the subgingival microbiota. J. Clin. Periodontol. 28, 377-388 (2001). (Pubitemid 33755454)
124. Zambon, J. J. Periodontal diseases: microbial factors. Ann. Periodontol. 1, 879-925 (1996).
125. Palmer, R. M ., Wilson, R. F ., Hasan, A. S. & Scott, D. A. Mechanisms of action of environmental factors-tobacco smoking. J. Clin. Periodontol. 32, 180-195 (2005). (Pubitemid 41391064)
126. Klareskog, L ., Malmstrom, V ., Lundberg, K ., Padyukov, L. & Alfredsson, L. Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Semin. Immunol. 23, 92-98 (2011).
127. Klareskog, L. et al. A new model for an etiology of rheumatoid arthritis. Arthritis Rheum. 54, 38-46 (2006).
128. Makrygiannakis, D. et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann. Rheum. Dis. 67, 1488-1492 (2008).
129. Padyukov, L ., Silva, C ., Stolt, P ., Alfredsson, L ., Klareskog, L. & Epidemiological Invest R A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum. 50, 3085-3092 (2004). (Pubitemid 39371983)
130. Linn-Rasker, S. P. et al. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann. Rheum. Dis. 65, 366-371 (2006). (Pubitemid 43268227)
131. Pedersen, M. et al. Strong combined gene-environment effects in anticyclic citrullinated peptide-positive rheumatoid arthritis-a nationwide case-control study in Denmark. Arthritis Rheum. 56, 1446-1453 (2007). (Pubitemid 46764072)
132. Lundstrom, E ., Kallberg, H ., Alfredsson, L ., Klareskog, L. & Padyukov, L. Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheum. 60, 1597-1603 (2009).
133. Hutchinson, D ., Shepstone, L ., Moots, R ., Lear, J. T. & Lynch, M. P. Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann. Rheum. Dis. 60, 223-227 (2001). (Pubitemid 32260603)
134. Kallberg, H. et al. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann. Rheum. Dis. 70, 508-511 (2011).
135. Karlson, E. W ., Lee, I. M ., Cook, N. R ., Manson, J. E ., Buring, J. E. & Hennekens, C. H. A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum. 42, 910-917 (1999). (Pubitemid 29215001)
136. Mikuls, T. R. et al. Antibody responses to Porphyromonas gingivalis in subjects with rheumatoid arthritis and periodontitis. Int. Immunopharmacol. 9, 38-42 (2009).
137. Finckh, A ., Dehler, S ., Costenbader, K. H ., Gabay, C. & SCQM. Cigarette smoking and radiographic progression in rheumatoid arthritis. Ann. Rheum. Dis. 66, 1066-1071 (2007). (Pubitemid 47122321)
138. Manfredsdottir, V. F. et al. The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis. Rheumatology 45, 734-740 (2006). (Pubitemid 43985343)
139. Papadopoulos, N. G ., Alamanos, Y ., Voulgarl, P. V ., Epagelis, E. K ., Tsifetaki, N. & Drosos, A. A. Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients?. Clin. Exp. Rheumatol. 23, 861-866 (2005). (Pubitemid 43040515)
140. Lee, H. S. et al. Interaction between smoking, the, shared epitope, and anti-cyclic citrullinated peptide-a mixed picture in three large North American rheumatoid arthritis cohorts. Arthritis Rheum. 56, 1745-1753 (2007).
141. Haffajee, A. D ., Bogren, A ., Hasturk, H ., Feres, M ., Lopez, N. J. & Socransky, S. S. Subgingival microbiota of chronic periodontitis subjects from different geographic locations. J. Clin. Periodontol. 31, 996-1002 (2004). (Pubitemid 39481833)
142. Masson-Bessiere, C. et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J. Immunol. 166, 4177-4184 (2001). (Pubitemid 32224951)
143. Vossenaar, E. R. et al. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res. Ther. 6, R142-R150 (2004).
144. Burkhardt, H ., Sehnert, B ., Bockermann, R ., Engstrom, A ., Kalden, J. R. & Holmdahl, R. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis. Eur. J. Immunol. 35, 1643-1652 (2005). (Pubitemid 40691444)
145. Lundberg, K. et al. Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res. Ther. 7, R458-R467 (2005).